The Journal of Medical Sciences

Register      Login

VOLUME 4 , ISSUE 2 ( April-June, 2018 ) > List of Articles


To evaluate Lipid Profiles in Patients with Chronic Kidney Disease in RajaRajeswari Medical College and Hospital, Bengaluru, Karnataka, India

Sharanappa Patil, V Ajith Kumar, Sandhya Subramani

Keywords : Chronic kidney disease, Dyslipidemia, Lipid profile

DOI: 10.5005/jp-journals-10045-0080

License: NA

Published Online: 01-08-2018

Copyright Statement:  NA


Background and objectives: Dyslipidemia is a fairly common occurrence in chronic renal failure (CRF) patients. Cardiovascular mortality in patients with CRF is related to dyslipidemia. This study was done to identify the lipid abnormalities and its significance in CRF patients by comparing with age, sex, and body mass index (BMI) of matched healthy control population. Materials and methods: In this study, 56 cases of CRF were taken and three fasting lipid profiles were estimated. Twentyfive age-, sex-, and BMI-matched healthy population were taken as controls. The data were entered in a master sheet and analyzed statistically. Results: Dyslipidemia is seen in CRF patients. Even though the total cholesterol was high in CRF cases compared with controls, the change was not significant statistically. Triglycerides showed a statistically significant increase in CRF cases. The low-density lipoprotein cholesterol (LDL-C) was elevated in CRF cases but the change was not significant statistically. The high-density lipoprotein cholesterol (HDL-C), on the contrary, showed a statistically significant drop compared with controls. Interpretation and results: Lipid abnormalities are common in CRF. Total cholesterol changes are not statistically significant. Triglycerides shows statistically significant increase in CRF cases when compared with normal. The LDL-C is increased in CRF patients, but it is not statistically significant when compared with controls. The HDL-C shows a statistically significant decrease in CRF patients compared with controls. These lipid abnormalities may be an important contributing factor to the cardiovascular mortality in patients with CRF.

PDF Share
  1. Dietary lipid metabolism and chronic renal failure. In: Davidson's principles & practice of medicine. 20th ed. pp. 444, 445, 485-496.
  2. Chronic kidney disease: Guidelines for GFR estimation. In: API text book of medicine. 8th ed. Vol. 1. p. 735.
  3. Lipid abnormalities in chronic kidney disease. In: Harrisons principles of internal medicine. 17th ed. Vol. 2. p. 1763.
  4. Lipid abnormality in CKD. In: Current medical diagnosis & treatment; 2008. pp. 793-800.
  5. Lipid abnormalities in chronic kidney disease. In: Oxford textbook of clinical nephrology. 2nd ed. Vol. 3. p. 1840.
  6. Lipid abnormalities in chronic kidney disease progression In: Brenner & Rector's, The Kidney, 7th ed. Vol. 2. p. 1975.
  7. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive disease. Lancet 1982 Dec 11;2(8311):1309-1311.
  8. Myhre E, Gjone E, Flatmark A, Hovig T. Renal failure in familial lecithine acetyltransferase deficiency. Nephron 1997;8:840-852.
  9. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients, risk factors, outcomes, and relationship with ischemic heart diseases. J Am Soc Nephrol 2002;13:1084-1090.
  10. Kimak E, Solski J, Janicka L, Duma D, Zagojska M. Plasmalipoproteins in patients with CRF. Int Urol Nephrol 1997;29(5):597-601.
  11. Bhagawat R, Joshi SP, Salgia P, Sepha A. Lipid abnormality in chronic renal failure. Indian J Clin Biochem 1997 Jan;12(1):81-85.
  12. Shah B, Nair S, Sirsat RA, Ashavaid TF, Nair KG. Dyslipidemia in patients with CRF and renal transplantation. J Postgrad Med 1994 Apr-Jun;40(2):57-60.
  13. Rajman J, Harpel L, McPake D, et al. Low density lipoprotein profile in CRF. Nephrol Dial Transplant 1998;13:2281.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.